Keryx Biopharmaceuticals Stock Price and Value Analysis

Should you buy Keryx Biopharmaceuticals stock? (NasdaqCM:KERX). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company has fluctuating growth.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

KERX Free Cash Flow Trend

Hmm, we can't give any reliable projection for Keryx Biopharmaceuticals's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for Keryx Biopharmaceuticals

Inside the KERX Numbers

KERX Price
(Keryx Biopharmaceuticals stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Biotechnology stocks
[?] Cash Yield -22.97%
[?] Free Cash Flow Jitter 28%

Is Keryx Biopharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Keryx Biopharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy KERX Stock?

Does Keryx Biopharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.